Heart BMJ

FEBRUARY 12, 2024

Objective This study assessed the long-term effects of triple therapy with prostanoids on patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD), as there is limited information on the safety and efficacy of this treatment approach.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Pulmonary 40

Journal of the American Heart Association

NOVEMBER 28, 2023

Transpulmonary exosomal miRs offer valuable insights into pulmonary circulation microenvironments. Using an in vitro flow model simulating the shear stress experienced by pulmonary endothelial cells, we observed a significant upregulation of miR‐21.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Pulmonary Heart Disease 40

Circulation: Cardiovascular Interventions

NOVEMBER 6, 2023

Background:Neonates with complex congenital heart disease and pulmonary overcirculation have been historically treated surgically. Pulmonary arteries grew adequately for age, and devices were easily removed without complications. However, subcohorts may benefit from less invasive procedures. months (IQR, 4.0–10.8),

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Pulmonary 40

Frontiers in Cardiovascular Medicine

JANUARY 14, 2024

Its use has been approved in the adult population with heart failure and described for pulmonary hypertension (PH). Only case reports and small series have been published about its use in the paediatric population and for congenital heart disease (CHD).

Congenital Heart Disease 59

Congenital Heart Disease Cardiomyopathy Congenital Heart Disease 59

All About Cardiovascular System and Disorders

FEBRUARY 14, 2024

Crochetage sign on ECG in ASD ECG in ASD with severe pulmonary hypertension: Tall R’ in V1, ST depression in inferior leads and V2-V5, and T inversion in inferior leads and V1-V6 are seen. All these features together in a cyanotic congenital heart disease is characteristic of tricuspid atresia.

Congenital Heart Disease 52

Congenital Heart Disease Congenital Heart Disease VSD 52

Frontiers in Cardiovascular Medicine

FEBRUARY 2, 2024

Aims A proportion of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) do not fit in the current classification.

Congenital Heart Disease 64

Congenital Heart Disease Congenital Pulmonary Hypertension 64

Frontiers in Cardiovascular Medicine

MAY 8, 2024

Patients with pulmonary hypertension associated with a left-right shunt include a wide spectrum of pathophysiological substrates, ranging from those characterized by pulmonary over-circulation to those with advanced pulmonary vascular disease.

Congenital Heart Disease 52

Congenital Heart Disease Pulmonary Hypertension Congenital 52

Open Heart

JULY 17, 2023

Congenital heart disease (CHD) is likely to increase vulnerability and understanding the predictors of adverse outcomes is key to optimising care. to 1.10 (p<0.01)) and with pulmonary arterial hypertension (PAH; OR 5.99, 95% CI 1.34 to 7.97 (p=0.01)) and genetic disease (OR 2.87, 95% CI 1.04 to 26.91 (p=0.02)).

COVID-19 40

COVID-19 Congenital Heart Disease Congenital Heart Disease 40

Journal of Cardiothoracic Surgery

MAY 10, 2024

Total anomalous pulmonary venous connection (TAPVC) is a rare congenital heart disease characterized by the inability of all pulmonary veins to connect to the left atrium. Our previous bibliometric article sum.

Pulmonary 52

Pulmonary Congenital Heart Disease Congenital Research 52

All About Cardiovascular System and Disorders

APRIL 17, 2024

Atrial septal defect – Ostium Primum, Ostium Secundum, Sinus Venosus Partial anomalous pulmonary venous return Atrioventricular septal defect Ventricular septal defect – inlet, outlet, perimembranous, muscular Patent ductus arteriosus Aortopulmonary window Coronary artery fistula draining to right heart Ruptured sinus of Valsalva aneurysm (..)

Congenital Heart Disease 52

Congenital Heart Disease Congenital Heart Disease Aneurysm 52

American College of Cardiology

OCTOBER 31, 2024

Tetralogy of Fallot (TOF) is the most common form of cyanotic congenital heart disease (CHD). Early management of this condition is typically dictated by the degree of pulmonary stenosis (PS) and resulting oxygen saturations.

Congenital Heart Disease 60

Congenital Heart Disease Congenital Stenosis Pulmonary 60

Journal of Cardiothoracic Surgery

JANUARY 22, 2024

The left partial anomalous pulmonary vein connection is a rare congenital heart disease, especially with intact atrial septum. Now we reported a case of the left superior pulmonary vein drainage to left innomi.

Pulmonary 52

Pulmonary Congenital Heart Disease Congenital Heart Disease 52

Dr. S. Venkatesan MD

NOVEMBER 6, 2024

PH is an important clinical cardio-pulmonary entity , which we confront day to day. The group 1 contains the famous , (now obsolete entity of primary pulmonary hypertension) Idiopathic PH , meaning that we don’t know the cause of it or we have excluded all known causes. The overlaps in etiology 1.The

Pulmonary 52

Pulmonary Hypertension Congenital Heart Disease Academic 52

The American Journal of Cardiology

JULY 9, 2024

Publication date: Available online 8 July 2024 Source: The American Journal of Cardiology Author(s): Emanuela Concetta D'Angelo, Gabriele Egidy Assenza, Anna Balducci, Ylenia Bartolacelli, Ambra Bulgarelli, Lucio Careddu, Cristina Ciuca, Elisabetta Mariucci, Luca Ragni, Andrea Donti, Gaetano Domenico Gargiulo, Emanuela Angeli

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Pulmonary 40

Circulation

NOVEMBER 11, 2024

Animal studies have shown that mice with TBX1 gene mutations have smaller left pulmonary arteries compared to wild type mice, defined by a reduced left pulmonary artery (LPA) to right pulmonary artery (RPA) ratio. A single study has shown this translates to humans with 22q11 and structurally normal hearts.

Pulmonary 40

Pulmonary Risk Factors Heart Disease Echocardiogram 40

The American Journal of Cardiology

SEPTEMBER 3, 2024

Publication date: Available online 2 September 2024 Source: The American Journal of Cardiology Author(s): Alexandra C. van Dissel, Michele D'Alto, Andrea Farro, Harold Mathijssen, Marco C. Post, Pier P. Bassareo, Arie P.J. van Dijk, Barbara J.M. Mulder, Berto J.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Pulmonary 40

Open Heart

SEPTEMBER 13, 2024

Background To determine the frequency of pregnancy complications and their association with the risk of cardiovascular outcomes in women with structural heart disease (SHD).

Heart Disease 52

Heart Disease Congenital Heart Disease Hypertension Congenital 52

HeartRhythm

MARCH 12, 2024

A 37-year-old woman with biventricular repair for pulmonary atresia and an intact ventricular septum was referred for an electrophysiological study in the context of recurrent atrial arrhythmias with multiple electrical cardioversions. Her clinical tachycardia was easily inducible and had a cycle length (TCL) of 340 ms.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Electrophysiology 40

Journal of Cardiothoracic Surgery

FEBRUARY 5, 2024

Fallot-type absent pulmonary valve is a rare and complex congenital heart disease. Repair surgery for this condition during the neonatal period has a mortality rate of over 50%. We reported a neonate with Fall.

Congenital Heart Disease 40

Congenital Heart Disease Pulmonary Congenital Heart Disease 40

American College of Cardiology

DECEMBER 19, 2023

This year saw exciting developments in the treatment of pediatric and congenital heart disease. Transcatheter pulmonary valve replacement (TPVR) continued to dominate the field of interventional cardiology.

Congenital 70

Congenital Pediatrics Congenital Heart Disease Interventional Cardiology 70

Frontiers in Cardiovascular Medicine

JULY 5, 2024

IntroductionPrimary pulmonary vein stenosis (PVS) is a rare congenital heart disease that proves to be a clinical challenge due to the rapidly progressive disease course and high rates of treatment complications.

Stenosis 52

Stenosis Pulmonary Congenital Heart Disease Stent 52

Frontiers in Cardiovascular Medicine

JANUARY 11, 2024

Objective Early risk assessment of pulmonary arterial hypertension (PAH) in patients with congenital heart disease (CHD) is crucial to ensure timely treatment. Class Activation Mapping (CAM) images demonstrated the model's attention focused on the pulmonary artery segment.

VSD 59

VSD Pulmonary Congenital Heart Disease Congenital 59

HeartRhythm

JANUARY 29, 2024

Tetralogy of Fallot (TOF) is the most prevalent form of cyanotic congenital heart disease and has become the poster child for the evolution and success of neonatal cardiac surgery.

Pulmonary 40

Pulmonary Congenital Heart Disease Arrhythmia Congenital 40

Frontiers in Cardiovascular Medicine

NOVEMBER 19, 2024

BackgroundWhile several studies have explored the outcomes of transcatheter interventions for modified Blalock–Taussig shunts (MBTSs) in a broad range of congenital heart diseases, none have specifically examined the interventions in patients with hypoplastic left heart syndrome (HLHS) who underwent Norwood palliation (NP).MethodsThis

Thrombosis 52

Thrombosis Stent Stents Congenital Heart Disease 52

HeartRhythm

APRIL 30, 2024

Patients with adult congenital heart disease are at risk for ventricular arrhythmias (VAs) or sudden cardiac death.

Sudden Cardiac Death 40

Sudden Cardiac Death Tachycardia Congenital Heart Disease Congenital 40

Frontiers in Cardiovascular Medicine

JULY 25, 2024

Nowhere is the need for fully absorbable metal stents greater than in patients experiencing vascular anomalies associated with congenital heart disease (CHD).

Stent 52

Stent Stents Pediatrics Congenital Heart Disease 52

All About Cardiovascular System and Disorders

JANUARY 14, 2024

Right Heart Catheterization in Tetralogy of Fallot With the availability of high resolution echocardiographic images and Doppler echocardiography, role of cardiac catheterization has come down in tetralogy of Fallot and other congenital heart diseases in general. Normal subjects have a value around 2.1.

Congenital Heart Disease 52

Congenital Heart Disease Pulmonary Anatomy Congenital 52

All About Cardiovascular System and Disorders

APRIL 1, 2024

Transcript of the video: Hemodynamic vise is the term given to compression of a vertical vein, which ascends to the brachiocephalic vein, between a bronchus and pulmonary artery. This produces a vicious cycle and that is why it is known as hemodynamic vise in certain types of congenital heart diseases which have a vertical vein.

Pulmonary 52

Pulmonary Congenital Heart Disease Congenital Heart Disease 52

All About Cardiovascular System and Disorders

MARCH 30, 2024

Transcript of video: Hypoplastic Left Heart Syndrome is a very severe form of congenital heart disease, in which, the left ventricle, aorta and mitral and aortic valves are hypoplastic and valves may be atretic as well. This is diagrammatic representation of hypoplastic left heart syndrome.

Aortic valve 52

Aortic valve Pulmonary Congenital Heart Disease Bicuspid/Mitral 52

Journal of the American Heart Association

JANUARY 31, 2024

Journal of the American Heart Association, Ahead of Print. BackgroundThe right ventricle (RV) is at risk in patients with complex congenital heart disease involving right‐sided obstructive lesions. We have shown that capillary rarefaction occurs early in the pressure‐loaded RV. Capillary rarefaction occurred immediately.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Pulmonary 40

Frontiers in Cardiovascular Medicine

FEBRUARY 11, 2024

Purpose This study aims to evaluate deep learning (DL) denoising reconstructions for image quality improvement of Doppler ultrasound (DUS)-gated fetal cardiac MRI in congenital heart disease (CHD). Methods Twenty-five fetuses with CHD (mean gestational age: 35 ± 1 weeks) underwent fetal cardiac MRI at 3T. vs. 8.3 ± 3.6,

Congenital Heart Disease 64

Congenital Heart Disease Ultrasound Congenital Aortic 64

Circulation: Cardiovascular Interventions

DECEMBER 28, 2023

BACKGROUND:Maldistribution of pulmonary blood flow in patients with congenital heart disease impacts exertional performance and pulmonary artery growth. Currently, measurement of relative pulmonary perfusion can only be performed outside the catheterization laboratory. P&lt;0.001).

Catheterization Laboratory 40

Catheterization Laboratory Congenital Heart Disease Laboratory Pulmonary 40

Journal of Cardiovascular Electrophysiology

JANUARY 11, 2024

Abstract Introduction Patients with congenital heart disease are at increased risk for requiring cardiac pacing during their lifetime.

Pacemaker 40

Pacemaker Congenital Heart Disease Congenital Anatomy 40

Frontiers in Cardiovascular Medicine

JANUARY 10, 2024

Herein, we compare conventional biplane angiography to multimodality image fusion with live fluoroscopy using two-dimensional (2D)–three-dimensional (3D) registration (MMIF 2D−3D ) and assess MMIF 2D−3D impact on radiation exposure and contrast volume during cardiac catheterization of patients with congenital heart disease (CHD).

Congenital 59

Congenital Angioplasty Congenital Heart Disease Stent 59

Frontiers in Cardiovascular Medicine

MAY 8, 2024

We describe a fetus with prenatal echocardiographic findings of BDA and right aortic arch mirror-image branching (RAA-MIB) combined with congenital heart disease. According to the double arch theory, BDA is formed when the distal ends of the sixth pairs of primitive arches on the left and right sides have not regressed.

Congenital Heart Disease 52

Congenital Heart Disease Aortic Pulmonary Ultrasound 52

All About Cardiovascular System and Disorders

MARCH 29, 2024

Transcript of video: Tetralogy of Fallot is one of the commonest cyanotic congenital heart diseases. One is ventricular septal defect, second is overriding aorta, third is pulmonary stenosis, usually right ventricular outflow tract stenosis and associated right ventricular hypertrophy. Right to left shunt is also visible.

Sudden Cardiac Death 52

Sudden Cardiac Death Pulmonary Stenosis Arrhythmia 52

Dr. S. Venkatesan MD

APRIL 18, 2024

Lowering the raised LA mean pressure is a major therapeutic goal in any severely symptomatic left heart disease, whether it is valvular or myocardial disease. This is to create a small regulatory orifice in the IAS ( A complicated term for a small ASD ) to decompress the LA and reduce pulmonary congestive symptoms.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Pulmonary Congenital Heart Disease VSD 40